Post- Judgment Interest Rate Reform: H. 3008 (2005)

|

Reduced post judgment interest from a flat 12 percent to


Reduced post judgment interest from a flat 12 percent to the prime rate plus four percent.

Latest News

View all news

SCOTUS Should Affirm Federal Law Supremacy With FDA Authority Case

The U.S. Supreme Court has a chance to rein in state court rulings that impose liability on pharmaceutical companies that go beyond, and even contradict, the federal regulatory process of the FDA, according to Tiger Joyce, president of the American Tort Reform Association. He explains why it is imperative the high court review a case involving Janssen Pharmaceuticals.